The global clinical laboratory diagnostic services market to reach nearly US$ 293 Million by 2023, growing at a CAGR of 5.5% over the forecast period, due to its unique advantage such as early disease diagnosis and rising geriatric population worldwide.
The clinical laboratory has recently been defined as ‘the nerve center of diagnostic medicine’ because it provides essential information not only for diagnosis and monitoring, but also for screening, prevention, early diagnosis, tailored treatment and the more effective monitoring of human diseases. Clinical laboratories provide testing primarily focused on medical care (e.g. emergency care, inpatients, and outpatient clinics).
The major changes experienced by laboratory medicine in the last few decades is the outcome of both technological and scientific progress. The shortened turnaround times to technological developments has made results available in real-time and dramatically improved the diagnosis and treatment of patients admitted to emergency departments and intensive care units. The availability of pivotal diagnostic information (e.g., blood-gas, electrolytes, disease biomarkers) at the point-of-care, and within a few minutes, allows clinicians to make evidence-based medical decisions and to immediately prioritize the treatment of patients. The extraordinary advancements in the molecular and biochemical bases of human diseases have paved the way for the introduction into the clinical practice of a new generation of laboratory tests for earlier and more accurate diagnoses, as well as for the identification of important risk factors.
The global clinical laboratory diagnostic services market report estimates the market size (US$ million 2015 to 2023) and segmented and forecast (CAGR% 2018 to 2023). It also analyses the major companies operating in the global market. The global clinical laboratory services market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global clinical laboratory services market and included in this report are Quest Diagnostics, Inc., Laboratory Corporation of America Holdings (LabCorp), Sonic Healthcare, Genoptix Medical Laboratory, Labco S.A., Healthscope Ltd., Bio-Reference Laboratories, and Bioscientia Healthcare.
The global clinical laboratory services market is segmented as:
- Clinical Diagnostics Test
- Clinical Chemistry
- Human & Tumor Genetics
- Medical Microbiology & Cytology
- Other Esoteric Tests
- Service Provider
- Geography (Region, Country)
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Rest of LA)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Rest of the World
- Company Profiles
- Abbott Laboratories
- ARUP Laboratories
- Bio-Reference Laboratories
- Bioscientia Healthcare
- Charles River Laboratories
- Genoptix Medical Laboratory
- Healthscope Ltd.
- Labco S.A.
- Laboratory Corporation of America Holdings (Labcorp)
- Quest Diagnostics, Inc.
- Sonic Healthcare Limited
- Spectra Laboratories
To request Table of Contents and Sample Pages of this report visit:
Global Clinical Laboratory Services Market US$ 293 Million by 2023